ACAD
NASDAQ
$25.09
Acadia Pharmaceuticals Inc (ACAD)
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company is headquartered in San Diego, California.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $32.65 (+30.13%)
Market Cap
$4.43B
PEG Ratio
0.19
P/E Ratio
11.73
Free Cash Flow Yield
2.56%
Price Chart
Valuation
Market Cap$4.43B
P/E11.73
Forward P/E76.34
PEG0.19
P/S3.98
P/B3.50
Profitability
Total Revenue (TTM)$1.10B
Gross Profit (TTM)$674M
EBITDA$82M
Profit Margin1.4%
Operating Margin-1.7%
EPS$2.21
Financial Health
Free Cash Flow Yield2.56%
Growth & Risk
Revenue 5Y CAGR+19.04%
Beta (5Y)0.90
Sharpe Ratio0.37